-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

114. Hemoglobinopathies, Excluding Thalassemia—Clinical: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Anemias, anticoagulant drugs, Coronaviruses, SARS-CoV-2/COVID-19, sickle cell disease, survivorship, Bleeding and Clotting, Diseases, drug-drug interaction, Non-Biological, sickle cell trait, Combinations, thalassemia, Therapies, Adverse Events, chemotherapy, Genetic Disorders, Pediatric, red blood cells, Biological Processes, Hemoglobinopathies, Technology and Procedures, Young Adult, Cell Lineage, Study Population, Thromboembolism, Clinically relevant, genomics, pharmacology, Quality Improvement , Thrombotic Disorders, WGS
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Alina Sadaf, MD1, Charles T. Quinn, MD2,3,4, Jennifer B Korpik3*, Amanda Pfeiffer, BS, MA2*, Mary Reynaud, MA, MT(ASCP)3*, Omar Niss, MD5, Punam Malik, MD2, Russell E. Ware, MD, PhD2, Theodosia A. Kalfa, MD, PhD2,3 and Patrick T. McGann, MD4,6

1Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3Erythrocyte Diagnostic Laboratory, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
4Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH
5Division of Hematology, Cincinnati Children's Hospital, Cincinnati, OH
6Division of Hematology, Children's Hospital Medical Center, Cincinnati, OH

Darla Liles, MD1, Kim Smith-Whitley, MD2, R Clark Brown, MD, PhD3, Nirmish Shah, MD4, Santosh M Nair, MD5, Chiaki Tanaka, PhD6*, Shankaranand Bodla7*, Gessami Sanchez-Olle, PhD8*, Urs Albers, PhD8* and Julie Kanter, MD9

1Division of Hematology–Oncology, East Carolina University, Greenville, NC
2Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA
3Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Atlanta, GA
4Duke University Medical Center, Durham, NC
5Mid Florida Hematology and Oncology Center, Orange City, FL
6Novartis Pharmaceuticals Corporation, East Hanover, NJ
7GCE Solutions, Manchester, United Kingdom
8Novartis Pharma AG, Basel, Switzerland
9Division of Hematology–Oncology, University of Alabama, Birmingham, AL

Jo Howard, MBBChir, MRCP, FRCPath1, Kenneth I. Ataga, MD2, R. Clark Brown, MD, PhD3, Maureen Achebe, MD, MPH4, Videlis Nduba, MD5*, Amal El-Beshlawy, MD6, Hoda Hassab, MD7*, Irene Agodoa, MD8*, Margaret Tonda, PharmD8*, Sarah Gray, PhD8*, Joshua Lehrer-Graiwer, MD, MPhil, FACC8 and Elliott Vichinsky, MD9

1Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom
2University of Tennessee Health Science Center at Memphis, Memphis, TN
3Department of Pediatrics, Aflac Cancer & Blood Disorders Center of Children’s Healthcare of Atlanta and the Department of Pediatrics, Emory University, Atlanta, GA
4Division of Hematology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
5Kenya Medical Research Institute, Kisumu, Kenya
6Cairo University, Cairo, Egypt
7Pediatric Department and Clinical Research Center Faculty of Medicine, Alexandria University Hospital, Alexandria, Egypt
8Global Blood Therapeutics, South San Francisco, CA
9UCSF Benioff Children's Hospital, Oakland, CA

Minke A.E. Rab, MD1,2*, Celeste K. Kanne, BA3*, Brigitte A. van Oirschot4*, Jennifer Bos5*, Camille Boisson6,7*, Maite E. Houwing, MD8*, Celine Renoux, PhD7,9,10*, Marije Bartels, MD, PhD11*, Erfan Nur, MD, PhD12, Marjon H. Cnossen, MD, PhD13*, Philippe Joly, PhD7,9,10*, Romain Fort, MD14*, Philippe Connes, PhD7,9,15*, Richard van Wijk, PhD4*, Vivien A. Sheehan, MD, PhD3 and Eduard van Beers, MD, PhD16*

1Van Creveldkliniek, UMC Utrecht, Utrecht University, Utrecht, Netherlands
2Department of Central Diagnostic Laboratory Research, University Medical Center Utrecht, Utrecht University, Utrecht, Utrecht, Netherlands
3Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX
4Department of Central Diagnostic Laboratory-Research, UMC Utrecht, Utrecht University, Utrecht, Netherlands
5Department of Central Diagnostic Laboratory-Research, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
6Laboratory of Excellence GR-Ex, Lyon, France
7Laboratory LIBM EA7424, University of Lyon 1, “Vascular Biology and Red Blood Cell” team, Lyon, France
8Department of Pediatric Hematology, Erasmus University Medical Center – Sophia Children’s Hospital, Rotterdam, The Netherlands, Rotterdam, Netherlands
9Laboratory of Excellence GR-Ex, Paris, France
10Laboratory of Biochemistry and Molecular Biology, UF Biochemistry of Red Blood Cell diseases, Est Center of Biology and Pathology, Hospices Civils de Lyon, Lyon, France
11Van Creveldkliniek, University Medical Center, Utrecht University, Utrecht, Netherlands
12Department of Clinical Hematology, Amsterdam University Medical Centers, Academic Medical Center, Amsterdam, Netherlands
13Dept. of Pediatric Hematology, Erasmus MC–Sophia Children’s Hospital, University Medical Center Rotterdam, Rotterdam, Netherlands
14Department of Internal Medicine, Hospices Civils de Lyon, Lyon, France
15Université Claude Bernard Lyon, Villeurbanne, FRA
16Van Creveldkliniek, University Medical Center Utrecht, University of Utrecht, Utrecht, Netherlands

Jin Han1*, Andrew Srisuwananukorn, MD2*, Michel Gowhari, DO3, Faiz Ahmed Hussain, MD4*, Franklin Njoku, MD5*, Robert E. Molokie, MD6, Victor R. Gordeuk, MD7 and Santosh L. Saraf, MD5

1Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL
2University of Illinois at Chicago, Chicago
3Division of Hematology/Oncology, University of Illinois at Chicago College of Medicine, Chicago, IL
4Division of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL
5Department of Medicine, University of Illinois at Chicago, Chicago, IL
6Department of Medicine, Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
7Sickle Cell Center, Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL

Richard Onalo, MBBS1*, Peter Cooper, MBBS2*, Barend C. Vorster, MD3*, Marli Dercksen, PhD4*, Antoinette Cilliers, MBBS5*, Uche Nnebe-Agumadu, MBBS6* and Claudia R. Morris, MD7,8

1Department of Pediatrics, University of Abuja, Abuja, Nigeria
2Department of Paediatrics, University of the Witwatersrand, Johannesburg, South Africa
3Centre for Human Metabolomics, North West University, Potchefstroom, South Africa
4North West University, Potchefstroom, South Africa
5Chris Hani Baragwanath Academic Hospital, University of Witwatersrand, Johannesburg, South Africa
6Department of Pediatrics, University of Abuja Teaching Hospital, Abuja, Nigeria
7Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
8Children's Healthcare of Atlanta, Atlanta, GA

Andrew M Heitzer, PhD1*, Jennifer Longoria, PhD1*, Evadnie Rampersaud, PhD2*, Sara Rashkin, PhD2*, Jeremie H. Estepp, MD3, Victoria Okhomina, MS4*, Winfred Wang, MD3, Darcy Raches, PhD1*, Brian Potter, PhD1*, Allison A. King, MD, MPH, PhD5, Guolian Kang, PhD4* and Jane S. Hankins, MD, MS6

1Department of Psychology, St. Jude Children's Research Hospital, Memphis, TN
2Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN
3Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
4Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
5Program in Occupational Therapy, Washington University in St. Louis, School of Medicine, Clayton, MO
6Associate Member, Director of the Sickle Cell Program, St. Jude Children's Research Hospital, Memphis, TN

Mahir Khan, MD1*, Andrew Srisuwananukorn, MD2*, Santosh L. Saraf, MD3, Faiz Ahmed Hussain, MD4*, Robert E. Molokie, MD5, Michel Gowhari, DO6, Victor R. Gordeuk, MD1 and Franklin Njoku, MD1*

1Department of Medicine, University of Illinois at Chicago, Chicago, IL
2University of Illinois at Chicago, Chicago
3Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL
4Division of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL
5Department of Medicine, Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
6Division of Hematology/Oncology, University of Illinois at Chicago College of Medicine, Chicago, IL

Daniel Adamkiewicz1*, Hongyan Xu, PhD2*, Latanya Bowman, RN1*, Leigh Wells, MSN1*, Niren Patel, MBBS1*, Ryan Harris, PhD, CEP, FACSM3*, Jennifer Pollock, PhD4*, David M. Pollock, PhD4*, Steffen E. Meiler, MD5* and Abdullah Kutlar, MD6

1Center for Blood Disorders, Augusta University/Medical College of Georgia, Augusta, GA
2Department of Epidemiology, Biostatistics and Population Science, Augusta University/Medical College of Georgia, Augusta, GA
3Georgia Prevention Institute, Augusta University/Medical College of Georgia, Augusta, GA
4Department of Medicine, Division of Nephrology, The University of Alabama at Birmingham, Birmingham, AL
5Dept. of Anesthesiology and Perioperative Medicine, Augusta University/Medical College of Georgia, Augusta, GA
6Center for Blood Disorders, Dr. William N. Agostas and Josephine R. Agostas Chair in Internal Medicine Medical College of Georgia, Augusta, GA

Modupe Idowu, MD1, Anam Haque, BS2* and Elisa M. Williams, BS2*

1Associate Professor, Medical Director, UT Physicians Comprehensive Sickle Cell Center, University of Texas Health Science Center, McGovern Medical School, Houston, TX
2UTHealth McGovern Medical School, Houston, TX

William B Ershler, MD1, Laura M De Castro, MD, MHSc2, Zahra Pakbaz, MD3, Aaron Moynahan4*, Derek Weycker, PhD4*, Nhat Pham4*, Thomas E Delea, MSIA4*, Irene Agodoa, MD5* and Ze Cong, PhD5*

1Benign Hematology Division, Inova Schar Cancer Institute, Falls Church, VA
2UPMC Hillman Cancer Center, Pittsburgh, PA
3UC Irvine Chao Family Cancer Center, Irvine, CA
4Policy Analysis Inc. (PAI), Brookline, MA
5Global Blood Therapeutics, South San Francisco, CA

Ashwin P Patel, MPH1*, Dorothy Kim Waller, PhD2* and Vivien A. Sheehan, MD, PhD3

1The University of Texas Health Science Center at Houston, Houston, TX
2The University of Texas Health Science Center-Houston (UTHealth), School of Public Health, Houston campus, Houston, TX
3Division of Hematology/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX

Lanetta Bronte-Hall, MD, MPH, MSPH1*, Biree Andemariam, MD2, Blyden Gershwin, MD1*, Sanne Lugthart, MD, PhD3*, Timothy Mant, MB, FFPM, FRCP4*, Jo Howard, MBBChir, MRCP, FRCPath4, Henry Fok, MBBS, PhD4*, Perla Eleftheriou, FRCPath, MRCP5*, Robert Ward Hagar, MD6, James Mason, DO7, Rahul Ballal, PhD8*, Joelle Lufkin, MPH8* and Eleanor Lisbon, MD, MPH8

1Foundation for Sickle Cell Disease Research, Hollywood, FL
2University of Connecticut, Farmington, CT
3University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
4Guy's and St. Thomas' Hospital, London, United Kingdom
5University College Hospital, London, United Kingdom
6UCSF Benioff Children's Hospital Oakland, Oakland, CA
7Baylor Scott and White, Temple, TX
8Imara, Boston, MA

Andrea Nowlin1*, Kristina Lai, MPH2*, Alexander Maillis, MPH3*, Patricia Waters, RN3*, Beatrice Gee, MD4 and Peter A. Lane, MD5

1Aflac Cancer and Blood Disorders Service, Children's Healthcare of Atlanta, ATLANTA, GA
2Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
3Aflac Cancer and Blood Disorders Service, Children's Healthcare of Atlanta, Atlanta, GA
4Children's Healthcare of Atlanta, Atlanta, GA
5Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA

Lauren E. Merz, MD MSc1*, Kavita Mistry, MD, PhD2*, Revital Freedman, PhD3*, Katherine L Jolley3*, Hae Soo Park3*, David M. Dorfman, MD, PhD4, Donna S. Neuberg, ScD5 and Maureen Achebe, MD, MPH3

1Department of Internal Medicine, Brigham & Women’s Hospital, Boston, MA
2Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA
3Division of Hematology, Brigham and Women's Hospital, Boston, MA
4Department of Pathology, Brigham and Women's Hospital, Boston, MA
5Department of Data Science, Dana-Farber Cancer Institute, Boston, MA

Ho Pui Jeff Lam1*, Jayanthi Alamelu2*, James Brighouse, MBBS FRPCH3*, Owen Miller, FRCPCH4*, Jonathan Lillie, PRCPCH5* and Baba PD Inusa, MD, MBBS6,7

1Paediatric Haematology , Evelina London Children's Hospital, Guy's and St Thomas NHS Foundation Trust, London, United Kingdom
2Guy's & St. Thomas' NHS Trust, London, GBR
3Evelina London Children's Hospital, Guy's and St Thomas NHS Foundation Trust, London, United Kingdom
4Department of Cardiology, Guy's and St Thomas NHS Foundation Trust, London, United Kingdom
5Paediatric Intensiv Care Unit, Guy's and St Thomas NHS Foundation Trust, London, United Kingdom
6Paediatric Haematology, Evelina Children's Hospital, Guy's and St Thomas' Hospital, London, United Kingdom
7Department of Women and Children, King's College London, London, United Kingdom

Alexandra Boye-Doe1, Elizabeth Brown2*, Charu Puri-Sharma, MS3*, Anjulika Chawla, MD3, Joshua J Field4*, Lynne D. Neumayr, MD5, Susan Padrino, MD6*, Payal Desai, MD7, Deepa Manwani, MD8, Sophie M. Lanzkron, MD, MHS9 and Jane A. Little, MD10

1Department of Medicine, University of North Carolina, Chapel Hill, NC
2Johns Hopkins University, Baltimore, MD
3bluebird bio, Cambridge, MA
4Bloodcenter of Wisconsin, Milwaukee, UMI
5Dept. of Hematology/Oncology, UCSF Benioff Children's Hospital Oakland, Oakland, CA
6University Hospital Cleveland Medical Center, Cleveland, OH
7The Ohio State University, Columbus, OH
8Division of Pediatric Hematology/Oncology, Department of Pediatrics, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY
9Department of Medicine, Division of Hematology, Johns Hopkins Medicine, Baltimore, MD
10University of North Carolina at Chapel Hill, Chapel Hill, NC

Alexander Glaros, MD1, Michael U. Callaghan, MD2,3 and Ahmar Urooj Zaidi, MD4,5

1Children's Hospital of Michigan, Department of Pediatrics, Division of Pediatric Hematology-Oncology, Central Michigan University, Detroit, MI
2Department of Pediatrics, Wayne State University, Detroit, MI
3Central Michigan University, Children’s Hospital of Michigan, Detroit, MI
4Wayne State University/Children's Hospital of Michigan/Detroit Medical Center, Carmen and Ann Adams Department of Pediatrics, Division of Hematology Oncology, Detroit, MI
5Central Michigan University, Children's Hospital of Michigan, Detroit, MI

Rita V Masese, MSc, MD1*, Dominique Bulgin, BSN, RN2*, Mitchell Knisely, PhD, RN1*, Liliana Preiss3*, Eleanor Stevenson, PhD, RN1*, Jane S. Hankins, MD, MS4, Marsha Treadwell, PhD5,6*, Allison A. King, MD, MPH, PhD7,8,9,10,11, Victor R. Gordeuk, MD12,13,14, Julie Kanter, MD15,16,17,18,19,20,21,22, Robert Gibson, MD23*, Jeffrey A. Glassberg, MD24,25, Paula Tanabe, PhD, RN26 and Nirmish Shah, MD27,28,29,30,31

1School of Nursing, Duke University, Durham, NC
2Duke University School of Nursing, Durham, NC
3RTI International, Durham, NC
4Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
5Children's Hospital and Research Center, Oakland, Oakland, CA
6UCSF Benioff Children's Hospital Oakland, Oakland, CA
7Washington University, St. Louis, Clayton, MO
8Program in Occupational Therapy, Washington University in St. Louis, School of Medicine, Clayton, MO
9Washington University in St. Louis, Clayton, MO
10Washington University, Saint Louis, MO
11Washington University School of Medicine, St. Louis, MO
12Sickle Cell Center, Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL
13University of Illinois at Chicago, Chicago, IL
14Department of Medicine, University of Illinois at Chicago, Chicago, IL
15Director, Adult Sickle Cell Program, Comprehensive Sickle Cell Center,, Birmingham, AL
16Division of Hematology–Oncology, University of Alabama, Birmingham, AL
17Hematology/Oncology, Comprehensive Sickle Cell Center, University of Alabama at Birmingham, Birmingham, AL
18University of Alabama, Director of the UAB Adult Sickle Cell Clinic Associate Professor in the Division of Hematology and Oncology, Birmingham, AL
19University of Alabama at Birmingham, Birmingham, AL
20Division of Pediatrics, Medical University of South Carolina, Charleston, SC
21Division of Hematology-Oncology, University of Alabama-Birmingham, Birmingham, AL
22Medical University Of South Carolina, Charleston, SC
23Medical College of Georgia, Augusta University, Augusta, GA
24Division of Hematology and Oncology, Department of Medicine and Department of Emergency Medicine, Mount Sinai Medical Center, New York, NY
25Division of Hematology Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
26School of Nursing/ School of Medicine, Duke University, Durham, NC
27Division of Hematology, Duke University School of Medicine, Durham, NC
28Duke University Medical Center, Durham, NC
29Duke University Health System, Durham, NC
30Duke University, Cary, NC
31Duke Adult Comprehensive Sickle Cell Center, Durham, NC

Jennifer G. Davila, MD1, W. Beau Mitchell, MD1, Kerry A Morrone, MD2, Ellen J Silver, PhD3*, Caterina P. Minniti, MD4, Henny H. Billett, MD, MSc5, Payal Desai, MD6, Sarah H. O'Brien, MD7 and Deepa Manwani, MD3,8

1Albert Einstein College of Medicine, Bronx, NY
2Children's Hospital At Montefiore, Bronx, NY
3Albert Einstein College of Medicine, Bronx
4Albert Einstein College of Medicine, New York, NY
5Division of Hematology, Department of Internal Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
6The Ohio State University, Columbus, OH
7Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, Nationwide Children's Hospital, Columbus, OH
8Children's Hospital at Montefiore, Bronx, NY

*signifies non-member of ASH